Moderna, Inc. (0QF.F)

EUR 37.5

(-3.85%)

Gross Profit Summary of Moderna, Inc.

Moderna, Inc.'s latest annual gross profit in 2023 was 2.06 Billion USD , down -85.12% from previous year.
Moderna, Inc.'s latest quarterly gross profit in 2024 Q2 was 106 Million USD , up 49.3% from previous quarter.
Moderna, Inc. reported a annual gross profit of 13.84 Billion USD in annual gross profit 2022, down -8.41% from previous year.
Moderna, Inc. reported a annual gross profit of 15.11 Billion USD in annual gross profit 2021, up 5571.96% from previous year.
Moderna, Inc. reported a quarterly gross profit of 106 Million USD for 2024 Q2, up 49.3% from previous quarter.
Moderna, Inc. reported a quarterly gross profit of 1.88 Billion USD for 2023 Q4, up 559.51% from previous quarter.

Annual Gross Profit Chart of Moderna, Inc. (2023 - 2016)

Historical Annual Gross Profit of Moderna, Inc. (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	2.06 Billion USD	-85.12%
2022	13.84 Billion USD	-8.41%
2021	15.11 Billion USD	5571.96%
2020	266.55 Million USD	454.91%
2019	48.03 Million USD	-64.44%
2018	135.06 Million USD	-23.68%
2017	176.97 Million USD	74.3%
2016	101.53 Million USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	71 Million USD	-96.23%
2024 Q2	106 Million USD	49.3%
2023 Q4	1.88 Billion USD	559.51%
2023 FY	2.06 Billion USD	-85.12%
2023 Q1	1.07 Billion USD	-66.2%
2023 Q2	-387 Million USD	-136.17%
2023 Q3	-410 Million USD	-5.94%
2022 Q3	2.12 Billion USD	-33.44%
2022 FY	13.84 Billion USD	-8.41%
2022 Q2	3.18 Billion USD	-35.3%
2022 Q1	4.92 Billion USD	-17.91%
2022 Q4	3.16 Billion USD	49.34%
2021 FY	15.11 Billion USD	5571.96%
2021 Q3	4.1 Billion USD	18.53%
2021 Q1	1.55 Billion USD	599.96%
2021 Q2	3.46 Billion USD	123.55%
2021 Q4	5.99 Billion USD	46.02%
2020 FY	266.55 Million USD	454.91%
2020 Q4	221.44 Million USD	1712.72%
2020 Q3	12.21 Million USD	-57.05%
2020 Q2	28.44 Million USD	538.14%
2020 Q1	4.45 Million USD	-57.77%
2019 FY	48.03 Million USD	-64.44%
2019 Q1	14.11 Million USD	-56.99%
2019 Q2	10.03 Million USD	-28.94%
2019 Q3	13.33 Million USD	32.98%
2019 Q4	10.55 Million USD	-20.88%
2018 Q3	36.66 Million USD	41.93%
2018 Q4	32.81 Million USD	-10.49%
2018 FY	135.06 Million USD	-23.68%
2018 Q1	27.46 Million USD	-68.94%
2018 Q2	25.83 Million USD	-5.93%
2017 Q4	88.41 Million USD	0.0%
2017 FY	176.97 Million USD	74.3%
2016 FY	101.53 Million USD	0.0%

Peer Gross Profit Comparison of Moderna, Inc.

Name	Gross Profit	Gross Profit Difference
BioNTech SE	3.21 Billion EUR	35.978%
CureVac N.V.	-70.6 Million EUR	3018.933%
Biotest Aktiengesellschaft	271.9 Million EUR	-657.999%
Biotest Aktiengesellschaft	271.9 Million EUR	-657.999%
BRAIN Biotech AG	30.12 Million EUR	-6742.175%
Formycon AG	23.3 Million EUR	-8743.596%
Heidelberg Pharma AG	6.6 Million EUR	-31098.513%
Medigene AG	4.39 Million EUR	-46836.916%